Literature DB >> 1905246

Radioimmunoassay for the determination of glycated haemoglobin.

Z Makita1, H Nakayama, S Taneda, M Kato, Y Kuroda, S Aoki, K Misawa, S Nakagawa.   

Abstract

A competitive radioimmunoassay for the quantitative determination of glycated haemoglobin was developed. The antiserum, obtained by immunizing guinea pigs with reduced glycated human albumin, was capable of identifying and quantitating the glucitollysine residues of glycated Hb after reduction with sodium borohydride. To simplify the sample preparation we introduced trichloroacetic acid precipitation to remove unreacted sodium borohydride instead of using dialysis or gel filtration. Using this procedure, our radioimmunoassay became relatively simple and provided satisfactory within- and between-run (1.3-2.8% and 1.9-5.4% coefficient of variation, respectively). The radioimmunoassay method was compared to the measurement of HbAlc by high performance liquid chromatography which is the most widely used method for quantitating glycated Hb. For this purpose glycated Hb was measured in normal glucose tolerance, impaired glucose tolerance, and diabetes mellitus groups based on WHO criteria. Both assays were able to discriminate between the normal and diabetic groups. In addition, while the determination of glycated Hb by the radioimmunoassay method was able to clearly discriminate between the normal and impaired glucose tolerance groups, the determination of HbAlc by the high performance liquid chromatography method failed to discriminate between these two groups. Moreover, 15 of the 20 impaired glucose tolerance patients exceeded the upper normal range (mean normal values + 2 SD) in radioimmunoassay. But all 20 patients with impaired glucose tolerance were within the upper normal range in HbAlc values. These results demonstrate that the measurement of glycated Hb by radioimmunoassay is more sensitive than the measurement of HbAlc by high performance liquid chromatography since it can discriminate between the normal and impaired glucose tolerance groups.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905246     DOI: 10.1007/bf00404023

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

1.  Proteins containing reductively aminated disaccharides. Synthesis and chemical characterization.

Authors:  B A Schwartz; G R Gray
Journal:  Arch Biochem Biophys       Date:  1977-06       Impact factor: 4.013

2.  Radioimmunoassay for nonenzymatically glycated protein in human serum.

Authors:  H Nakayama; S Taneda; N Manda; S Aoki; K Komori; Y Kuroda; K Misawa; S Tsushima; S Nakagawa
Journal:  Clin Chim Acta       Date:  1986-08-15       Impact factor: 3.786

Review 3.  Glycated hemoglobin: methodologies and clinical applications.

Authors:  D E Goldstein; R R Little; H M Wiedmeyer; J D England; E M McKenzie
Journal:  Clin Chem       Date:  1986-10       Impact factor: 8.327

4.  National Diabetes Data Group: report of the expert committee on glucosylated hemoglobin.

Authors:  J W Baynes; H F Bunn; D Goldstein; M Harris; D B Martin; C Peterson; K Winterhalter
Journal:  Diabetes Care       Date:  1984 Nov-Dec       Impact factor: 19.112

5.  The clinical information value of the glycosylated hemoglobin assay.

Authors:  D M Nathan; D E Singer; K Hurxthal; J D Goodson
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

6.  Quantitation of lysine-bound glucose of normal and diabetic erythrocyte membranes by HPLC analysis of furosine [ epsilon-N(L-furoylmethyl)-L-lysine].

Authors:  E Schleicher; L Scheller; O H Wieland
Journal:  Biochem Biophys Res Commun       Date:  1981-04-15       Impact factor: 3.575

7.  Sites of nonenzymatic glycosylation of human hemoglobin A.

Authors:  R Shapiro; M J McManus; C Zalut; H F Bunn
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

8.  Kinetic analysis of glycation as a tool for assessing the half-life of proteins.

Authors:  E Schleicher; O H Wieland
Journal:  Biochim Biophys Acta       Date:  1986-10-29

9.  A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins.

Authors:  L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

Review 10.  The clinical utility of glycosylated hemoglobin.

Authors:  L Jovanovic; C M Peterson
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

View more
  1 in total

1.  Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol.

Authors:  Y Al-Abed; T Mitsuhashi; H Li; J A Lawson; G A FitzGerald; H Founds; T Donnelly; A Cerami; P Ulrich; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.